The levels of visceral adipose tissue-derived serpin, omentin-1 and tumor necrosis factor-α in the gingival crevicular fluid of obese patients following periodontal therapy

Journal of Oral Science

Volumn 58, Issue 4, 2016, Pages 465-473

  Balli, Umut ^a   Bozkurt Dogan, Seyma ^b   Ongoz Dede, Figen ^c   Sertoglu, Erdim ^d   Keles, Goncacayır ^e  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

^b YILDIRIM BEYAZIT UNIVERSITY   (Turkey)

^c ORDU UNIVERSITY   (Turkey)

^d GULHANE SCHOOL OF MEDICINE   (Turkey)

^e ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Human; Obesity; Omentin 1 protein; Periodontal disease; Tumor necrosis factor alpha; Visceral adipose specific serpin

Indexed keywords

CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN; SERINE PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR;

ADULT; COMPLICATION; FEMALE; GINGIVITIS; HUMAN; INTRAABDOMINAL FAT; MALE; METABOLISM; MIDDLE AGED; OBESITY; PERIODONTITIS;

ADULT; CYTOKINES; FEMALE; GINGIVAL CREVICULAR FLUID; GPI-LINKED PROTEINS; HUMANS; INTRA-ABDOMINAL FAT; LECTINS; MALE; MIDDLE AGED; OBESITY; PERIODONTITIS; SERPINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85007328470     PISSN: 13434934     EISSN: 18804926     Source Type: Journal    
DOI: 10.2334/josnusd.16-0212     Document Type: Article

References (54)

1. Formiguera X, Cant�n A (2004) Obesity: epidemiology and clinical aspects. Best Pract Res Clin Gastroenterol 18, 1125-1146.
2. Al-Zahrani MS, Bissada NF, Borawski EA (2003) Obesity and periodontal disease in young, middle-aged, and older adults. J Periodontol 74, 610-615.
3. Gursoy UK, Marakoglu I, Ersan S (2006) Periodontal status and cytoplasmic enzyme activities in gingival crevicular fluid of type 2 diabetic and/or obese patients with chronic periodontitis. J Int Acad Periodontol 8, 2-5.
4. Linden G, Patterson C, Evans A, Kee F (2007) Obesity and periodontitis in 60-70-year-old men. J Clin Periodontol 34, 461-466.
5. Yl�stalo P, Suominen-Taipale L, Reunanen A, Knuuttila M (2008) Association between body weight and periodontal infection. J Clin Periodontol 35, 297-304.
6. Khader YS, Bawadi HA, Haroun TF, Alomari M, Tayyem RF (2009) The association between periodontal disease and obesity among adults in Jordan. J Clin Periodontol 36, 18-24.
7. Kushiyama M, Shimazaki Y, Yamashita Y (2009) Relationship between metabolic syndrome and periodontal disease in Japanese adults. J Periodontol 80, 1610-1615.
8. Saxlin T, Yl�stalo P, Suominen-Taipale L, Aromaa A, Knuuttila M (2010) Overweight and obesity weakly predict the development of periodontal infection. J Clin Periodontol 37, 1059-1067.
9. de Castilhos ED, Horta BL, Gigante DP, Demarco FF, Peres KG, Peres MA (2012) Association between obesity and periodontal disease in young adults: a population-based birth cohort. J Clin Periodontol 39, 717-724.
10. Genco RJ, Grossi SG, Ho A, Nishimura F, Murayama Y (2005) A proposed model linking inflammation to obesity, diabetes, and periodontal infections. J Periodontol 76, 2075-2084.
11. Saito T, Shimazaki Y, Kiyohara Y, Kato I, Kubo M, Iida M et al. (2005) Relationship between obesity, glucose tolerance, and periodontal disease in Japanese women: the Hisayama study. J Periodontal Res 40, 346-353.
12. Pradeep AR, Karvekar S, Nagpal K, Patnaik K (2015) Vaspin: a new adipokine correlating the levels of crevicular fluid and tear fluid in periodontitis and obesity. J Investig Clin Dent doi: 10.1111/jicd.12149.
13. Gon�alves TE, Zimmermann GS, Figueiredo LC, Souza M de C, da Cruz DF, Bastos MF et al. (2015) Local and serum levels of adipokines in patients with obesity after periodontal therapy: one-year follow-up. J Clin Periodontol 42, 431-439.
14. Gorman A, Kaye EK, Apovian C, Fung TT, Nunn M, Garcia RI (2012) Overweight and obesity predict time to periodontal disease progression in men. J Clin Periodontol 39, 107-114.
15. Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A et al. (2005) Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci U S A 102, 10610-10615.
16. Brunetti L, Di Nisio C, Recinella L, Chiavaroli A, Leone S, Ferrante C et al. (2011) Effects of vaspin, chemerin and omentin-1 on feeding behavior and hypothalamic peptide gene expression in the rat. Peptides 32, 1866-1871.
17. Wang YM, Wang WP, Wang LP, L� QH, Zhou XH (2010) Calorie control increased vaspin levels of serum and periepididymal adipose tissue in diet-induced obese rats in association with serum free fatty acid and tumor necrosis factor alpha. Chin Med J (Engl) 123, 936-941.
18. de Souza Batista CM, Yang RZ, Lee MJ, Glynn NM, Yu DZ, Pray J et al. (2007) Omentin plasma levels and gene expression are decreased in obesity. Diabetes 56, 1655-1661.
19. Pan HY, Guo L, Li Q (2010) Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract 88, 29-33.
20. Senolt L, Polansk� M, Filkov� M, Cerezo LA, Pavelka K, Gay S et al. (2010) Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis. Ann Rheum Dis 69, 1410-1411.
21. Zhong X, Zhang HY, Tan H, Zhou Y, Liu FL, Chen FQ et al. (2011) Association of serum omentin-1 levels with coronary artery disease. Acta Pharmacol Sin 32, 873-878.
22. Yamawaki H, Tsubaki N, Mukohda M, Okada M, Hara Y (2010) Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels. Biochem Biophys Res Commun 393, 668-672.
23. Zhong X, Li X, Liu F, Tan H, Shang D (2012) Omentin inhibits TNF-α-induced expression of adhesion molecules in endothelial cells via ERK/NF-κB pathway. Biochem Biophys Res Commun 425, 401-406.
24. Zimmermann GS, Bastos MF, Dias Goncalves TE, Chambrone L, Duarte PM (2013) Local and circulating levels of adipocytokines in obese and normal weight individuals with chronic periodontitis. J Periodontol 84, 624-633.
25. World Health Organization (2008) Waist circumference and waist-hip ratio: report of a WHO expert consultation, Geneva, 1-47.
26. Armitage GC (1999) Development of a classification system for periodontal diseases and conditions. Ann Periodontol 4, 1-6.
27. Silness J, L�e H (1964) Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 22, 121-135.
28. L�e H, Silness J (1963) Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 21, 533-551.
29. Ainamo J, Bay I (1975) Problems and proposals for recording gingivitis and plaque. Int Dent J 25, 229-235.
30. TM). A case series. J Clin Periodontol 33, 491-499.
31. Griffiths GS (2003) Formation, collection and significance of gingival crevice fluid. Periodontol 2000 31, 32-42.
32. Champagne CM, Buchanan W, Reddy MS, Preisser JS, Beck JD, Offenbacher S (2003) Potential for gingival crevice fluid measures as predictors of risk for periodontal diseases. Periodontol 2000 31, 167-180.
33. Lamster IB, Oshrain RL, Fiorello LA, Celenti RS, Gordon JM (1988) A comparison of 4 methods of data presentation for lysosomal enzyme activity in gingival crevicular fluid. J Clin Periodontol 15, 347-352.
34. Lin SJ, Chen YL, Kuo MY, Li CL, Lu HK (2005) Measurement of gp130 cytokines--oncostatin M and IL-6 in gingival crevicular fluid of patients with chronic periodontitis. Cyto-kine 30, 160-167.
35. Ouchi N, Parker JL, Lugus JJ, Walsh K (2011) Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11, 85-97.
36. Trayhurn P, Wood IS (2005) Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 33, 1078-1081.
37. Leal V de O, Mafra D (2013) Adipokines in obesity. Clin Chim Acta 419, 87-94.
38. Ozgen M, Koca SS, Dagli N, Balin M, Ustundag B, Isik A (2010) Serum adiponectin and vaspin levels in rheumatoid arthritis. Arch Med Res 41, 457-463.
39. El-Mesallamy HO, Kassem DH, El-Demerdash E, Amin AI (2011) Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus. Metabolism 60, 63-70.
40. Kadoglou NP, Gkontopoulos A, Kapelouzou A, Fotiadis G, Theofilogiannakos EK, Kottas G et al. (2011) Serum levels of vaspin and visfatin in patients with coronary artery disease-Kozani study. Clin Chim Acta 412, 48-52.
41. Derosa G, Fogari E, D’Angelo A, Bianchi L, Bonaventura A, Romano D et al. (2013) Adipocytokine levels in obese and non-obese subjects: an observational study. Inflammation 36, 914-920.
42. Cura HS, �zdemir HH, Demir CF, Bulut S, Ilhan N, Inci MF (2014) Investigation of vaspin level in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis 23, 453-456.
43. Esteghamati A, Noshad S, Mousavizadeh M, Zandieh A, Nakhjavani M (2014) Association of vaspin with metabolic syndrome: the pivotal role of insulin resistance. Diabetes Metab J 38, 143-149.
44. Youn BS, Kl�ting N, Kratzsch J, Lee N, Park JW, Song ES et al. (2008) Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 57, 372-377.
45. Phalitakul S, Okada M, Hara Y, Yamawaki H (2011) Vaspin prevents TNF-α-induced intracellular adhesion molecule-1 via inhibiting reactive oxygen species-dependent NF-κB and PKCθ activation in cultured rat vascular smooth muscle cells. Pharmacol Res 64, 493-500.
46. Jung CH, Lee WJ, Hwang JY, Lee MJ, Seol SM, Kim YM et al. (2012) Vaspin increases nitric oxide bioavailability through the reduction of asymmetric dimethylarginine in vascular endothelial cells. PLoS One 7, e52346.
47. Yang RZ, Lee MJ, Hu H, Pray J, Wu HB, Hansen BC et al. (2006) Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 290, E1253-1261.
48. Yamawaki H, Kuramoto J, Kameshima S, Usui T, Okada M, Hara Y (2011) Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochem Biophys Res Commun 408, 339-343.
49. Tan BK, Adya R, Farhatullah S, Chen J, Lehnert H, Randeva HS (2010) Metformin treatment may increase omentin-1 levels in women with polycystic ovary syndrome. Diabetes 59, 3023-3031.
50. Auguet T, Quintero Y, Riesco D, Morancho B, Terra X, Crescenti A et al. (2011) New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Med Genet 12, 60.
51. Sitticharoon C, Nway NC, Chatree S, Churintaraphan M, Boonpuan P, Maikaew P (2014) Interactions between adiponectin, visfatin, and omentin in subcutaneous and visceral adipose tissues and serum, and correlations with clinical and peripheral metabolic factors. Peptides 62, 164-175.
52. Duzagac E, Cifcibasi E, Erdem MG, Karabey V, Kasali K, Badur S et al. (2015) Is obesity associated with healing after non-surgical periodontal therapy? A local vs. systemic evaluation. J Periodontal Res 51, 604-612.
53. �ng�z Dede F, Bozkurt Doğan Ş, Balli U, Avci B, Durmuşlar MC, Baratzade T (2016) Glutathione levels in plasma, saliva and gingival crevicular fluid after periodontal therapy in obese and normal weight individuals. J Periodontal Res doi: 10.1111/jre.12349.
54. Gon�alves TE, Feres M, Zimmermann GS, Faveri M, Figueiredo LC, Braga PG et al. (2015) Effects of scaling and root planing on clinical response and serum levels of adipocytokines in patients with obesity and chronic periodontitis. J Periodontol 86, 53-61.